Section one: Contracting authority
one.1) Name and addresses
NHS Blood and Transplant
500 North Bristol Park
Bristol
BS34 7QH
Contact
Sahithi Bandi
Telephone
+44 7385149017
Country
United Kingdom
Region code
UKK11 - Bristol, City of
Internet address(es)
Main address
Buyer's address
one.3) Communication
Additional information can be obtained from the above-mentioned address
Electronic communication requires the use of tools and devices that are not generally available. Unrestricted and full direct access to these tools and devices is possible, free of charge, at
https://health-family.force.com/s/Welcome
one.4) Type of the contracting authority
Body governed by public law
one.5) Main activity
Health
Section two: Object
two.1) Scope of the procurement
two.1.1) Title
Supply of Cryopreservation bags for use in Reagents
two.1.2) Main CPV code
- 33140000 - Medical consumables
two.1.3) Type of contract
Supplies
two.1.4) Short description
Supply of Cryopreservation bags for use in Reagents
NHSBT Reagents and TES Production are located at the Speke, Liverpool site. NHSBT Reagents is a department within the Clinical Services. NHSBT TES is a department within the Organ and Tissue Donation Transplant Directorate of National Health Service Blood and Transplant (NHSBT).
NHSBT Reagents manufacture a range of in Vitro Diagnostic devices and applies the CE Mark (where appropriate) in accordance with 98/79/EC or the UKCA Mark (where appropriate) in accordance with the UK MDR 2002. Cryopreservation bags are used within Reagents to store red cells with cryoprotectant solution.
Cryopreservation packaging bags are used routinely as part of the cryopreservation of a range of different human tissue products alongside cryoprotectant solution so must conform to the business and functional requirements listed below. These products are produced under license from the HTA.
NHSBT now wishes to commence a formal procurement process and is seeking to engage with suppliers and understand the market.
Business Requirements
• The quality of the stored cells and tissue grafts in the cryopreservation bag must be maintained and the Supplier must refrain from any activity which may adversely affect the quality of the manufactured product.
• The cost-effectiveness of the packaging must be maintained or improved.
• The system must meet current Health and Safety legislation (Health and Safety at Work Act 1974
• The supplier must be able to hold a contingency stock of a minimum of two months’ supply.
• Detailed specification will be shared while scheduling the premarket engagement call.
It is NHSBT's intention to hold pre-procurement supplier engagement meetings the week of 11th July to 9th August 2024. The meetings will be held remotely, the dates are to be confirmed. To enable NHSBT to finalise arrangements (e.g., send meeting details and agree time slots) for the meeting’s, interested organisations are required to send an expression of interest via email to Sahithi Bandi sahithi.bandi@nhsbt.nhs.uk by no later than 17:00 hrs (GMT) on 06/08/2024. This should include a list of your potential attendees and a brief overview (or a website link) of the Goods / Services which might be offered. Please include options, if available, for a managed service contract.
No business whatsoever is guaranteed under any resulting framework agreement or contract, and there is no guarantee that any framework agreement or contract will be put in place in relation to this notice. No compensation etc. will be paid if a tender or resulting framework agreement is withdrawn for any reason. Bidders should take part in this process only on the basis that they fully understand and accept this position.
It should be noted that this procurement exercise may allow other Health authorities to use any agreements awarded.
two.1.5) Estimated total value
Value excluding VAT: £150,000
two.1.6) Information about lots
This contract is divided into lots: No
two.2) Description
two.2.3) Place of performance
NUTS codes
- UKK11 - Bristol, City of
two.2.4) Description of the procurement
Supply of Cryopreservation bags for use in Reagents
NHSBT Reagents and TES Production are located at the Speke, Liverpool site. NHSBT Reagents is a department within the Clinical Services. NHSBT TES is a department within the Organ and Tissue Donation Transplant Directorate of National Health Service Blood and Transplant (NHSBT).
NHSBT Reagents manufacture a range of in Vitro Diagnostic devices and applies the CE Mark (where appropriate) in accordance with 98/79/EC or the UKCA Mark (where appropriate) in accordance with the UK MDR 2002. Cryopreservation bags are used within Reagents to store red cells with cryoprotectant solution.
Cryopreservation packaging bags are used routinely as part of the cryopreservation of a range of different human tissue products alongside cryoprotectant solution so must conform to the business and functional requirements listed below. These products are produced under license from the HTA.
NHSBT now wishes to commence a formal procurement process and is seeking to engage with suppliers and understand the market.
Business Requirements
• The quality of the stored cells and tissue grafts in the cryopreservation bag must be maintained and the Supplier must refrain from any activity which may adversely affect the quality of the manufactured product.
• The cost-effectiveness of the packaging must be maintained or improved.
• The system must meet current Health and Safety legislation (Health and Safety at Work Act 1974
• The supplier must be able to hold a contingency stock of a minimum of two months’ supply.
• Detailed specification will be shared while scheduling the premarket engagement call.
It is NHSBT's intention to hold pre-procurement supplier engagement meetings the week of 11th July to 9th August 2024. The meetings will be held remotely, the dates are to be confirmed. To enable NHSBT to finalise arrangements (e.g., send meeting details and agree time slots) for the meeting’s, interested organisations are required to send an expression of interest via email to Sahithi Bandi sahithi.bandi@nhsbt.nhs.uk by no later than 17:00 hrs (GMT) on 06/08/2024. This should include a list of your potential attendees and a brief overview (or a website link) of the Goods / Services which might be offered. Please include options, if available, for a managed service contract.
No business whatsoever is guaranteed under any resulting framework agreement or contract, and there is no guarantee that any framework agreement or contract will be put in place in relation to this notice. No compensation etc. will be paid if a tender or resulting framework agreement is withdrawn for any reason. Bidders should take part in this process only on the basis that they fully understand and accept this position.
It should be noted that this procurement exercise may allow other Health authorities to use any agreements awarded.
two.3) Estimated date of publication of contract notice
10 July 2024
Section four. Procedure
four.1) Description
four.1.8) Information about the Government Procurement Agreement (GPA)
The procurement is covered by the Government Procurement Agreement: Yes